(3,5-DIOXO-2,3,4,5-TETRAHYDRO-[1,2,4]TRIAZIN-6-YLAMINO)-ACETIC ACID BUTYL ESTER
![]() |
- $378 - $874
- Product name: (3,5-DIOXO-2,3,4,5-TETRAHYDRO-[1,2,4]TRIAZIN-6-YLAMINO)-ACETIC ACID BUTYL ESTER
- CAS: 307524-88-5
- MF: C9H14N4O4
- MW: 242.23
- EINECS:
- MDL Number:MFCD00226038
- Synonyms:(3,5-DIOXO-2,3,4,5-TETRAHYDRO-[1,2,4]TRIAZIN-6-YLAMINO)-ACETIC ACID BUTYL ESTER;Butyl 2-((3,5-dihydroxy-1,2,4-triazin-6-yl)amino)acetate;Glycine, N-(2,3,4,5-tetrahydro-3,5-dioxo-1,2,4-triazin-6-yl)-, butyl ester;Butyl (3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazin-6-yl)glycinate
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500MG
- 1g
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0080871
- Product description(3,5-DIOXO-2,3,4,5-TETRAHYDRO-[1,2,4]TRIAZIN-6-YLAMINO)-ACETIC ACID BUTYL ESTER 95.00%
- Packaging500MG
- Price$796.95
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11148618
- Product descriptionButyl2-((3,5-dihydroxy-1,2,4-triazin-6-yl)amino)acetate 97%
- Packaging5g
- Price$874
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number032669
- Product description(3,5-Dioxo-2,3,4,5-tetrahydro-[1,2,4]triazin-6-ylamino)-acetic acid butyl ester
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0080871 | (3,5-DIOXO-2,3,4,5-TETRAHYDRO-[1,2,4]TRIAZIN-6-YLAMINO)-ACETIC ACID BUTYL ESTER 95.00% | 500MG | $796.95 | 2021-12-16 | Buy |
Crysdot | CD11148618 | Butyl2-((3,5-dihydroxy-1,2,4-triazin-6-yl)amino)acetate 97% | 5g | $874 | 2021-12-16 | Buy |
Matrix Scientific | 032669 | (3,5-Dioxo-2,3,4,5-tetrahydro-[1,2,4]triazin-6-ylamino)-acetic acid butyl ester | 1g | $378 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|